Success and Outcomes Following a Second Salvage Attempt for Free Flap Compromise in Patients Undergoing Head and Neck Reconstruction.


Journal

JAMA otolaryngology-- head & neck surgery
ISSN: 2168-619X
Titre abrégé: JAMA Otolaryngol Head Neck Surg
Pays: United States
ID NLM: 101589542

Informations de publication

Date de publication:
01 06 2022
Historique:
pubmed: 28 4 2022
medline: 14 6 2022
entrez: 27 4 2022
Statut: ppublish

Résumé

Incidence of perioperative free flap compromise is low, with successful salvage in up to 70%. When the flap is compromised a second time, the value of intervening is unknown. To assess the outcomes of a second revascularization attempt for compromised free flaps. This multicenter retrospective medical record review included patients undergoing head and neck reconstruction with free flaps at 6 US medical centers from January 1, 2000, through December 30, 2020. Patients were 18 years or older with a history of head and neck defects from cancer, osteoradionecrosis, or other wounds. Of 3510 flaps identified, 79 were successfully salvaged once, became compromised a second time, and underwent attempted salvage. Flaps with a history of initial compromise and successful revascularization demonstrating second episodes of compromise followed by second salvage attempts. A total of 79 patients (mean age, 64 years; 61 [77%] men) were included in the analysis. Of the 79 flaps undergoing second salvage attempts, 24 (30%) survived while 55 (70%) demonstrated necrosis. Arterial or venous thrombectomy was performed in 17 of the 24 (71%) flaps that survived and 23 of the 55 (42%) flaps demonstrating necrosis (odds ratio, 3.38; 95% CI, 1.21-9.47). When venous compromise was encountered, changing the anastomotic vein was associated with decreased survival compared with not changing the vein (29 of 55 [53%] flaps vs 10 of 24 [42%] flaps); vein revision to an alternative branch was completed in 1 of the 24 (4%) flaps that survived and 19 of the 55 (35%) flaps with necrosis (odds ratio, 0.08; 95% CI, 0.00-0.60). Factors that were not associated with flap survival following second salvage attempts included flap type, cause of flap failure, postoperative complications, patient comorbidities, and heparin administration after second salvage. In this cohort study, second salvage was successful in 30% of free flaps. Flaps that underwent arterial or venous thrombectomy demonstrated better survival, while vein revision to neighboring branch veins was associated with worse flap outcomes.

Identifiants

pubmed: 35476871
pii: 2791782
doi: 10.1001/jamaoto.2022.0793
pmc: PMC9047712
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

555-560

Auteurs

Allison A Slijepcevic (AA)

Department of Otolaryngology-Head & Neck Surgery, School of Medicine, Oregon Health & Science University, Portland.

Gavin Young (G)

School of Medicine, Oregon Health & Science University, Portland.

Justin Shinn (J)

Department of Otorhinolaryngology-Head & Neck Surgery, University of Pennsylvania, Philadelphia.

Steven B Cannady (SB)

Department of Otorhinolaryngology-Head & Neck Surgery, University of Pennsylvania, Philadelphia.

Matthew Hanasono (M)

Department of Plastic Surgery, The University of Texas MD Anderson Cancer Center, Houston.

Matthew Old (M)

Department of Otolaryngology-Head & Neck Surgery, College of Medicine, The Ohio State University, Columbus.

Jeewanjot S Grewal (JS)

Department of Otolaryngology-Head & Neck Surgery, Henry Ford Health System, Detroit, Michigan.

Tamer Ghanem (T)

Department of Otolaryngology-Head & Neck Surgery, Henry Ford Health System, Detroit, Michigan.

Yadranko Ducic (Y)

Head & Neck Cancer Center of Texas, Dallas.

Joseph M Curry (JM)

Department of Otolaryngology-Head & Neck Surgery, Jefferson University Hospitals, Philadelphia, Pennsylvania.

Mark K Wax (MK)

Department of Otolaryngology-Head & Neck Surgery, School of Medicine, Oregon Health & Science University, Portland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH